The TGFBI R555W mutation induces a new granular corneal dystrophy type I phenotype.
OBJECTIVE
To report the clinical and molecular features of a distinct form of transforming growth factor-β-induced (TGFBI) gene-linked corneal dystrophy exhibiting a new granular corneal dystrophy type I (CDGG1) phenotype.


METHODS
A complete ophthalmologic examination was performed in all individuals of a Chinese family in which autosomal dominant transmission of the disease had been observed. DNA was obtained from the peripheral blood leukocytes of each participating subject. Genetic analyses included keratin 3 (KRT3), keratin 12 (KRT12), and TGFBI polymerase chain reaction (PCR) amplification and automated nucleotide sequencing of exons from the genomic DNA.


RESULTS
The corneal phenotype in this pedigree was characterized by multiple bilateral dot-like, circular opacities at different corneal depths, with some of the affected individuals only having opacities in the epithelium, which is different from the typical CDGG1 phenotype. TGFBI analysis revealed a heterozygous point mutation at exon 12 (c.1663C>T) in all of the affected individuals, predicting a p.R555W missense mutation.


CONCLUSIONS
The phenotype which resulted from the TGFBI R555W mutation in this family is distinct from that observed in the typical case of CDGG1. We propose this disorder should be classified as a new phenotype of CDGG1, and this finding demonstrates the importance of gene diagnosis in the corneal dystrophies.
Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.
Yanan
Y
Zhu
Xingchao
X
Shentu
Wei
W
Wang
D002681:China; D003317:Corneal Dystrophies, Hereditary / Q000235:genetics*; D004252:DNA Mutational Analysis; D005091:Exons; D005192:Family Health; D005260:Female; D006579:Heterozygote; D006801:Humans; D008297:Male; D009154:Mutation; D020125:Mutation, Missense; D010375:Pedigree; D010641:Phenotype; D017354:Point Mutation; D053773:Transforming Growth Factor beta1 / Q000235:genetics*
D053773:Transforming Growth Factor beta1
Invest Ophthalmol Vis Sci. 2005 Jan;46(1):121-5
15623763
Nat Genet. 1997 Mar;15(3):247-51
9054935
Orphanet J Rare Dis. 2009 Feb 23;4:7
19236704
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2973-9
12824240
Cornea. 2005 Nov;24(8):928-32
16227835
FEBS Lett. 2000 Nov 3;484(2):164-8
11068053
Br J Ophthalmol. 2010 Jul;94(7):836-42
19948560
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):949-54
11923233
Am J Pathol. 1998 Mar;152(3):743-8
9502416
Semin Ophthalmol. 2008 Jan-Feb;23(1):9-17
18214787
Arch Ophthalmol. 2007 Feb;125(2):177-86
17296893
Exp Eye Res. 1998 Jun;66(6):739-45
9657906
Cornea. 2008 Dec;27 Suppl 2:S1-83
19337156
Structure. 2003 Feb;11(2):197-203
12575939
Curr Opin Ophthalmol. 2006 Aug;17(4):361-6
16900028
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2213-9
10476785
Ophthalmic Genet. 2005 Dec;26(4):169-73
16352477
Front Biosci. 2003 May 01;8:d687-713
12700042
J Biol Chem. 2011 Feb 18;286(7):4951-8
21135107
Genomics. 1997 Nov 15;46(1):152-4
9403072
Hum Mutat. 2006 Jul;27(7):615-25
16683255
Jpn J Ophthalmol. 2008 May-Jun;52(3):224-226
18661274